Lauren Bresner1, Rita Banach, Gary Rodin, Lehana Thabane, Shereen Ezzat, Anna M Sawka. 1. Division of Endocrinology (L.B.), Department of Medicine, Toronto General Hospital, Toronto, ON M5G 2C4, Canada; Thyroid Cancer Canada (R.B.), Toronto, ON M5N 3A8, Canada; Department of Psychosocial Oncology (G.R.), Princess Margaret Hospital, Toronto, ON M5G 2M9, Canada; Department of Clinical Epidemiology and Biostatistics (L.T.), St. Joseph's Healthcare and McMaster University, Hamilton, ON L8N 4A6, Canada; and Division of Endocrinology (S.E., A.M.S.), University Health Network and University of Toronto, Toronto, ON M5G 2N2, Canada.
Abstract
CONTEXT: Little is known about cancer-related worry in thyroid cancer survivors. OBJECTIVES: We quantified cancer-related worry in Canadian thyroid cancer survivors and explored associated factors. DESIGN, SETTING, AND PARTICIPANTS: We performed a cross-sectional, self-administered, written survey of thyroid cancer survivor members of the Thyroid Cancer Canada support group. Independent factors associated with cancer-related worry were identified using a multivariable linear regression analysis. MAIN OUTCOME MEASURE: We used the Assessment of Survivor Concerns (ASC) questionnaire, which includes questions on worry about diagnostic tests, second primary malignancy, recurrence, dying, health, and children's health. RESULTS: The response rate for eligible members was 60.1% (941 of 1567). Most respondents were women (89.0%; 837 of 940), and the age was < 50 years in 54.0% of participants (508 of 941). Thyroid cancer was diagnosed within ≤ 5 years in 66.1% of participants (622 of 940). The mean overall ASC score was 15.34 (SD, 4.7) (on a scale from 6 [least worry] to 24 [most worry]). Factors associated with increased ASC score included: younger age (P < .001), current suspected or proven recurrent/persistent disease (ie, current proven active disease or abnormal diagnostic tests) (P < .001), partnered marital status (P = .021), having children (P = .029), and ≤5 years since thyroid cancer diagnosis (P = .017). CONCLUSIONS: In a population of Canadian thyroid cancer survivors, cancer-related worry was greatest in younger survivors and those with either confirmed or suspected disease activity. Family status and time since thyroid cancer diagnosis were also associated with increased worry. More research is needed to confirm these findings and to develop effective preventative and supportive strategies for those at risk.
CONTEXT: Little is known about cancer-related worry in thyroid cancer survivors. OBJECTIVES: We quantified cancer-related worry in Canadian thyroid cancer survivors and explored associated factors. DESIGN, SETTING, AND PARTICIPANTS: We performed a cross-sectional, self-administered, written survey of thyroid cancer survivor members of the Thyroid Cancer Canada support group. Independent factors associated with cancer-related worry were identified using a multivariable linear regression analysis. MAIN OUTCOME MEASURE: We used the Assessment of Survivor Concerns (ASC) questionnaire, which includes questions on worry about diagnostic tests, second primary malignancy, recurrence, dying, health, and children's health. RESULTS: The response rate for eligible members was 60.1% (941 of 1567). Most respondents were women (89.0%; 837 of 940), and the age was < 50 years in 54.0% of participants (508 of 941). Thyroid cancer was diagnosed within ≤ 5 years in 66.1% of participants (622 of 940). The mean overall ASC score was 15.34 (SD, 4.7) (on a scale from 6 [least worry] to 24 [most worry]). Factors associated with increased ASC score included: younger age (P < .001), current suspected or proven recurrent/persistent disease (ie, current proven active disease or abnormal diagnostic tests) (P < .001), partnered marital status (P = .021), having children (P = .029), and ≤5 years since thyroid cancer diagnosis (P = .017). CONCLUSIONS: In a population of Canadian thyroid cancer survivors, cancer-related worry was greatest in younger survivors and those with either confirmed or suspected disease activity. Family status and time since thyroid cancer diagnosis were also associated with increased worry. More research is needed to confirm these findings and to develop effective preventative and supportive strategies for those at risk.
Authors: Laura P Forsythe; Catherine M Alfano; Corinne R Leach; Patricia A Ganz; Michael E Stefanek; Julia H Rowland Journal: J Clin Oncol Date: 2012-07-09 Impact factor: 44.544
Authors: Nancy K Janz; Sarah T Hawley; Mahasin S Mujahid; Jennifer J Griggs; Amy Alderman; Ann S Hamilton; John J Graff; Reshma Jagsi; Steven J Katz Journal: Cancer Date: 2011-03-28 Impact factor: 6.860
Authors: Kristin M Phillips; Heather L McGinty; Brian D Gonzalez; Heather S L Jim; Brent J Small; Susan Minton; Michael A Andrykowski; Paul B Jacobsen Journal: Psychooncology Date: 2012-03-15 Impact factor: 3.894
Authors: Kim Wagler Ziner; George W Sledge; Cynthia J Bell; Shelley Johns; Kathy D Miller; Victoria L Champion Journal: Oncol Nurs Forum Date: 2012-05-01 Impact factor: 2.172
Authors: Sophie Lebel; Christina Tomei; Andrea Feldstain; Sara Beattie; Megan McCallum Journal: Support Care Cancer Date: 2012-12-27 Impact factor: 3.603
Authors: Maria Papaleontiou; Mousumi Banerjee; Di Yang; James C Sisson; Ronald J Koenig; Megan R Haymart Journal: Thyroid Date: 2013-02 Impact factor: 6.568
Authors: Maria Papaleontiou; David Reyes-Gastelum; Brittany L Gay; Kevin C Ward; Ann S Hamilton; Sarah T Hawley; Megan R Haymart Journal: Thyroid Date: 2019-07-25 Impact factor: 6.568
Authors: Briseis Aschebrook-Kilfoy; Benjamin James; Sapna Nagar; Sharone Kaplan; Vanessa Seng; Habibul Ahsan; Peter Angelos; Edwin L Kaplan; Marlon A Guerrero; Jennifer H Kuo; James A Lee; Elliot J Mitmaker; Jacob Moalem; Daniel T Ruan; Wen T Shen; Raymon H Grogan Journal: Thyroid Date: 2015-12-01 Impact factor: 6.568
Authors: Bryan R Haugen; Erik K Alexander; Keith C Bible; Gerard M Doherty; Susan J Mandel; Yuri E Nikiforov; Furio Pacini; Gregory W Randolph; Anna M Sawka; Martin Schlumberger; Kathryn G Schuff; Steven I Sherman; Julie Ann Sosa; David L Steward; R Michael Tuttle; Leonard Wartofsky Journal: Thyroid Date: 2016-01 Impact factor: 6.568
Authors: Brenna E Blackburn; Patricia A Ganz; Kerry Rowe; John Snyder; Yuan Wan; Vikrant Deshmukh; Michael Newman; Alison Fraser; Ken Smith; Kimberly Herget; Jaewhan Kim; Anne C Kirchhoff; Christina Porucznik; Heidi Hanson; Marcus Monroe; Mia Hashibe Journal: Cancer Epidemiol Biomarkers Prev Date: 2017-11-22 Impact factor: 4.254